Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/30/2026, 2:41:24 PM
sha256:30c59Content snapshot
{ "nct_id": "NCT04556656", "phase": "phase_3", "status": "completed", "domain": "huntingtons", "indication": "Manifest Huntington's Disease", "intervention": "Pridopidine 45mg BID (sigma-1 receptor agonist)", "sponsor": "Prilenia Therapeutics", "n_enrolled": 499, "primary_endpoint": "cUHDRS at 65 weeks", "summary": "Failed primary on cUHDRS; subgroup analyses suggested benefit in patients not on anti-dopaminergic background therapy.", "metadata": {} }